GO:0032496 response to lipopolysaccharide: Innate Immune Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032496 response to lipopolysaccharide describes any process by which a cell or organism changes state or activity after exposure to lipopolysaccharide (LPS), a major component of the gram-negative bacterial cell wall.
• LPS triggers rapid transcriptional and signaling changes in monocytes, macrophages, dendritic cells, epithelial cells, and airway smooth muscle, including cytokine production and altered contractility.
• The response is highly context-dependent: it differs by species, breed, tissue, and disease state, such as hypertension with coronary artery disease or microgravity exposure.
• Key signaling nodes include TLR4, MYD88, NF-kB, MAPK/ERK1/2, and inflammatory cytokines such as TNF, IL6, and IL1B.
• Experimental models range from LPS-stimulated primary monocytes and macrophage-like cells to knockout mice and in vivo challenge in pigs and ewes.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models enable causal testing of candidate genes within the LPS response network.
Description
GO:0032496 response to lipopolysaccharide is a biological process term that captures the full set of cellular and organismal changes triggered by lipopolysaccharide (LPS), also called endotoxin, a major structural component of the gram-negative bacterial cell wall. The term is intentionally broad: it includes changes in movement, secretion, enzyme production, gene expression, and other activities that occur after LPS stimulation. Because LPS is a canonical activator of innate immunity, this GO term is central to immunology, inflammation research, sepsis biology, and host-pathogen interaction studies. Researchers use this term to annotate genes and pathways that respond to LPS across diverse experimental systems, from primary immune cells to whole animals. The response is not monolithic; it varies by cell type, species, genetic background, and environmental context. For example, monocytes from hypertensive coronary artery disease patients show an attenuated LPS response linked to a specific gene network, and microgravity activates monocyte ERK1/2 signaling while modulating the LPS response. Breed-specific differences in ewes further illustrate genetic control of this process. Understanding GO:0032496 therefore requires integrating signaling, transcriptional, and functional data across models.
response to lipopolysaccharide At A Glance
| GO ID | GO:0032496 |
|---|---|
| GO term | response to lipopolysaccharide |
| Ontology | biological_process |
| Synonym | response to endotoxin; response to LPS |
| Major function | Coordinated cellular and organismal response to LPS, including signaling, transcription, cytokine secretion, and functional changes |
| Definition source | QuickGO definition: Any process that results in a change in state or activity of an organism as a result of a lipopolysaccharide stimulus |
| Typical cell types | Monocytes, macrophages, dendritic cells, epithelial cells, airway smooth muscle, and others |
| Key pathways | TLR4, MYD88, NF-kB, MAPK/ERK, cytokine networks |
| Model organisms | Pig, mouse, sheep, human primary cells |
What Is GO:0032496?
In practical terms, GO:0032496 response to lipopolysaccharide refers to any process that results in a change in state or activity of an organism, cell, or tissue as a result of an LPS stimulus. This includes rapid signal transduction events, changes in gene expression, secretion of cytokines and other mediators, alterations in cell movement, and modifications in enzyme production. The term is agnostic to the specific receptor or downstream pathway, encompassing TLR4-dependent and TLR4-independent mechanisms, and applies across species from mouse to human to livestock.
Why Is response to lipopolysaccharide Important in Cell Biology?
GO:0032496 is important because LPS is a primary trigger of innate immune activation and a key driver of sepsis, acute inflammation, and inflammatory disease exacerbations. The response to LPS determines whether an organism mounts a protective immune reaction or suffers from excessive inflammation. Genetic and environmental factors that modulate this response influence susceptibility to infections, chronic inflammatory diseases, and even cardiovascular outcomes. Studying this process helps identify therapeutic targets and biomarkers for conditions ranging from septic shock to airway disease.
• LPS is a major component of gram-negative bacterial cell walls and a potent activator of innate immunity.
• The response to LPS is central to sepsis, endotoxemia, and acute inflammatory syndromes.
• Genetic variation alters LPS responsiveness, as shown by breed-specific differences in ewes and divergent selection in pigs.
• Disease states such as hypertension with coronary artery disease can attenuate monocyte LPS responses.
• Environmental factors like microgravity modulate LPS-induced signaling in monocytes.
• Airway smooth muscle contractility can be altered by LPS exposure in genetically modified mice.
• Dendritic cell responses to LPS and dying cells differ between cord and adult blood.
• Macrophage-like cells respond to LPS from oral bacteria such as Fusobacterium nucleatum.
• Epithelial innate immune responses to bacterial components are relevant in chronic rhinosinusitis.
• CRISPR models enable causal dissection of genes within the LPS response network.
What Happens During response to lipopolysaccharide?
Recognition and immediate signaling
In simple terms: The cell detects LPS and flips a switch that starts a signaling cascade.
LPS is recognized by pattern recognition receptors, most notably TLR4, leading to activation of intracellular adaptors such as MYD88. This triggers phosphorylation cascades including MAPK/ERK1/2, which has been observed in monocytes under microgravity conditions. The immediate signaling phase involves changes in kinase activity and transcription factor activation, setting the stage for broader transcriptional responses.
Transcriptional reprogramming
In simple terms: The cell changes which genes are turned on or off.
Following receptor activation, transcription factors such as NF-kB and AP-1 drive expression of hundreds of genes, including cytokines, chemokines, and adhesion molecules. Studies in monocytes from hypertensive coronary artery disease patients identified a gene network driving an attenuated LPS response, highlighting inter-individual variability in transcriptional reprogramming. In pigs divergently selected for residual feed intake, acute systemic inflammatory responses to LPS differ, reflecting genetic control of transcription.
Cytokine and mediator secretion
In simple terms: The cell releases chemical messages that call immune cells and amplify inflammation.
A hallmark of the LPS response is secretion of pro-inflammatory cytokines such as TNF, IL6, and IL1B. Macrophage-like cells stimulated with Fusobacterium nucleatum LPS show differential cytokine responses. Dendritic cells from cord blood and adult blood exhibit differential responses to dying cells and LPS, indicating developmental regulation of secretion.
Functional and physiological changes
In simple terms: The response can change how organs and tissues work, not just immune cells.
LPS exposure can alter contractile responses of small airways, as shown in GSTCD-/- mice. In ewes, breed-specific differences in the immune response to LPS indicate genetic influence on physiological outcomes. These functional changes demonstrate that GO:0032496 extends beyond immune cells to tissue-level physiology.
Resolution and feedback
In simple terms: The response is eventually dampened to avoid endless inflammation.
Negative feedback mechanisms, including anti-inflammatory cytokines and regulatory pathways, help resolve the LPS response. The gene network identified in hypertensive coronary artery disease patients suggests that impaired feedback or attenuated activation can occur in disease states. Proper resolution is critical to prevent chronic inflammation.
Key Genes Involved in GO:0032496 response to lipopolysaccharide
The following genes and proteins are commonly studied in the context of GO:0032496 response to lipopolysaccharide, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | LPS recognition receptor | Core initiator of LPS signaling; target for KO and point-mutation studies |
| MYD88 | Adaptor protein downstream of TLR4 | Central to signal transduction; knockout models available |
| NFKB1 | Transcription factor subunit | Drives pro-inflammatory gene expression; key node in LPS response |
| MAPK1/ERK2 | Kinase in MAPK pathway | Activated by LPS; modulated by microgravity |
| TNF | Pro-inflammatory cytokine | Secreted after LPS stimulation; biomarker of response |
| IL6 | Pro-inflammatory cytokine | Induced by LPS; used to measure response magnitude |
| IL1B | Pro-inflammatory cytokine | Key mediator of LPS-induced inflammation |
| GSTCD | Glutathione S-transferase domain containing | Knockout alters airway contractile response to LPS |
| CD14 | LPS co-receptor | Facilitates LPS presentation to TLR4 |
| LY96 (MD-2) | LPS-binding accessory protein | Required for TLR4 activation |
| IRAK1 | Kinase downstream of MYD88 | Propagates LPS signaling |
| TRAF6 | E3 ubiquitin ligase | Activates NF-kB and MAPK pathways |
| CXCL8 (IL8) | Chemokine | Recruits neutrophils; induced by LPS |
| CCL2 | Chemokine | Recruits monocytes; induced by LPS |
| SOCS1 | Negative regulator of cytokine signaling | Dampens LPS response |
| NFKBIA (IkBa) | Inhibitor of NF-kB | Feedback regulator of LPS response |
| DUSP1 | MAPK phosphatase | Negative feedback on ERK signaling |
How Is response to lipopolysaccharide Regulated?
The response to lipopolysaccharide is tightly regulated at multiple levels. Negative feedback loops involving SOCS proteins, NFKBIA, and DUSP1 dampen signaling after initial activation. In disease states, such as hypertensive coronary artery disease, a gene network can attenuate the monocyte LPS response. Environmental factors like microgravity can modulate ERK1/2 signaling and alter the response to LPS. Genetic background also plays a role, as shown by breed-specific differences in ewes and divergent selection in pigs. These regulatory layers ensure that the response is appropriate in magnitude and duration.
response to lipopolysaccharide and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR4 | Sepsis, endotoxemia | Knockout mice, point-mutation knock-in |
| GSTCD | Airway contractility | GSTCD-/- mouse |
| NFKB1 | Inflammatory disease | Overexpression and knockout cell lines |
| MAPK1 | Microgravity-associated immune modulation | ERK1/2 signaling assays in monocytes |
| IL6 | Cytokine storm, inflammation | Reporter knock-in for IL6 expression |
Sepsis and acute inflammation
Excessive or dysregulated response to LPS is a hallmark of sepsis and endotoxemia. Acute systemic inflammatory responses to LPS in pigs divergently selected for residual feed intake demonstrate genetic control of this process. Understanding GO:0032496 is therefore critical for developing therapies for septic shock.
Cardiovascular disease
Monocytes from hypertensive coronary artery disease patients show an attenuated response to LPS, linked to a specific gene network. This suggests that LPS response pathways contribute to cardiovascular disease biology and may serve as therapeutic targets.
Airway and respiratory disease
LPS exposure reduces contractile responses of small airways in GSTCD-/- mice. Epithelial innate immune responses to bacterial components are also relevant in chronic rhinosinusitis. These findings link GO:0032496 to respiratory pathophysiology.
Oral and mucosal inflammation
Macrophage-like cells respond to LPS from Fusobacterium nucleatum, an oral pathogen, indicating a role for LPS response in periodontal and mucosal inflammation. Dendritic cell responses to LPS vary with developmental origin, which may influence mucosal immunity.
From response to lipopolysaccharide-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate LPS-induced cytokine production? | CRISPR knockout in macrophage cell line |
| Does a point mutation in TLR4 alter LPS sensitivity? | Point-mutation knock-in in monocytes |
| Can overexpression of a negative regulator dampen LPS response? | Overexpression cell model |
| How does a tagged protein localize after LPS stimulation? | Tagged knock-in with imaging |
| Which genes are essential for LPS response in vivo? | Knockout mouse challenged with LPS |
| What is the transcriptional signature of LPS response? | RNA-seq of LPS-stimulated primary cells |
How to Study the response to lipopolysaccharide Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify LPS-responsive genes and networks |
| Phosphoproteomics | Kinase activation | Measure ERK1/2 phosphorylation after LPS |
| ELISA | Cytokine secretion | Quantify TNF, IL6, IL1B release |
| Flow cytometry | Surface markers, intracellular signaling | Analyze monocyte and dendritic cell responses |
| Western blot | Protein expression and phosphorylation | Validate signaling changes in knockout models |
| CRISPR screening | Gene essentiality | Identify regulators of LPS response |
| Bioinformatics | Pathway enrichment | Interpret transcriptomic data in GO context |
Transcriptomics (RNA-seq)
RNA-seq measures global gene expression changes after LPS stimulation, revealing the transcriptional landscape of GO:0032496. This approach identified gene networks driving attenuated LPS responses in hypertensive coronary artery disease patients and breed-specific differences in ewes.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics quantifies protein abundance and phosphorylation events, such as ERK1/2 activation, after LPS exposure. This method identifies signaling nodes and potential biomarkers.
Cytokine assays
ELISA and multiplex assays measure secretion of TNF, IL6, IL1B, and other cytokines in response to LPS. These are standard readouts for functional validation of CRISPR models.
Imaging and flow cytometry
Flow cytometry quantifies surface marker expression and intracellular signaling in immune cells after LPS stimulation. Imaging can track NF-kB translocation or protein localization in live cells.
How CRISPR Can Be Used to Study GO:0032496 response to lipopolysaccharide
Knockout
CRISPR knockout of candidate genes such as TLR4, MYD88, or NFKB1 in macrophage cell lines or primary monocytes can determine whether they are required for LPS-induced cytokine production. This approach is validated by studies showing that GSTCD knockout alters airway responses to LPS.
Point Mutation
Point-mutation knock-in can model naturally occurring variants in genes like TLR4 or MAPK1 that alter LPS sensitivity. This is useful for studying genetic differences in LPS response observed across breeds or patient populations.
Knock-in
Knock-in of reporter genes (e.g., GFP or luciferase) under the control of LPS-responsive promoters allows real-time monitoring of transcriptional activation. Tagged knock-in of signaling proteins enables localization studies.
Overexpression
Overexpression of negative regulators such as SOCS1 or NFKBIA can dampen LPS responses, providing gain-of-function evidence. Conversely, overexpression of TLR4 or MYD88 can enhance sensitivity to LPS.
How EDITGENE Supports response to lipopolysaccharide Research
Researchers studying response to lipopolysaccharide-related genes often need to determine whether a candidate gene is causally involved in LPS sensing, signaling, or downstream effector functions. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for response to lipopolysaccharide research.
Frequently Asked Questions About response to lipopolysaccharide
What is GO:0032496 response to lipopolysaccharide?
GO:0032496 is a Gene Ontology biological process term describing any process that results in a change in state or activity of an organism as a result of a lipopolysaccharide stimulus.
What genes are involved in response to lipopolysaccharide?
Key genes include TLR4, MYD88, NFKB1, MAPK1, TNF, IL6, IL1B, and GSTCD, among others.
How is the LPS response measured in cells?
Common methods include RNA-seq, cytokine ELISA, phosphoproteomics, and flow cytometry.
What is the difference between LPS and endotoxin?
LPS and endotoxin are often used interchangeably; LPS is a major component of the gram-negative bacterial cell wall and a potent endotoxin.
Can CRISPR be used to study LPS response genes?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect gene function in LPS response.
What cell types respond to LPS?
Monocytes, macrophages, dendritic cells, epithelial cells, and airway smooth muscle cells all respond to LPS.
Does the LPS response differ between individuals?
Yes, genetic background and disease state can alter LPS responsiveness, as shown in pigs, ewes, and hypertensive coronary artery disease patients.
What diseases are linked to LPS response?
Sepsis, cardiovascular disease, airway disease, and oral inflammation are linked to LPS response.
How does microgravity affect LPS response?
Microgravity activates monocyte ERK1/2 signaling and modulates the response to LPS.
What is the role of GSTCD in LPS response?
GSTCD knockout mice show reduced contractile response of small airways after LPS exposure.
Conclusion
GO:0032496 response to lipopolysaccharide is a fundamental biological process that bridges innate immunity, inflammation, and tissue physiology. Its complexity, shaped by genetic, environmental, and disease-specific factors, makes it a rich area for research. CRISPR-based models and multi-omics approaches are essential tools for dissecting the gene networks and signaling pathways involved. EDITGENE offers comprehensive services to support these investigations.
References
- 1. Liu H et al.. 2019. Acute systemic inflammatory response to lipopolysaccharide stimulation in pigs divergently selected for residual feed intake.. BMC Genomics 20(1):728 PMID: 31610780
- 2. Liu B et al.. 2019. Exposure to lipopolysaccharide (LPS) reduces contractile response of small airways from GSTCD-/- mice.. PLoS One 14(9):e0221899 PMID: 31513609
- 3. Lu C et al.. 2024. Identification of a gene network driving the attenuated response to lipopolysaccharide of monocytes from hypertensive coronary artery disease patients.. Front Immunol 15:1286382 PMID: 38410507
- 4. Mammadov RA et al.. 2025. Microgravity activates monocyte ERK1/2 signaling and modulates the response to lipopolysaccharide.. Mol Med 32(1):2 PMID: 41318416
- 5. Hadfield JM et al.. 2018. Breed-specific differences in the immune response to lipopolysaccharide in ewes.. J Anim Sci 96(10):4220-4228 PMID: 30107562
- 6. Wong OH et al.. 2005. Differential responses of cord and adult blood-derived dendritic cells to dying cells.. Immunology 116(1):13-20 PMID: 16108813
- 7. Grenier D et al.. 2006. Response of human macrophage-like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharide.. Oral Microbiol Immunol 21(3):190-6 PMID: 16626377
- 8. Li P et al.. 2023. Epithelial innate immune response to Pseudomonas aeruginosa-derived flagellin in chronic rhinosinusitis.. Int Forum Allergy Rhinol 13(10):1937-1948 PMID: 37057820
